| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |